Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Acquisition

3 Dec 2024 07:00

RNS Number : 5001O
Derwent London PLC
03 December 2024
 

3 December 2024

Derwent London plc ("Derwent London" / "the Group") Acquisition of remaining 50% in 50 Baker Street W1 scheme

Derwent London is pleased to announce that it has acquired the remaining 50% stake in its proposed 50 Baker Street W1 scheme from Lazari Investments, its joint venture partner, for £44.4m (£370 psf on consented floor area). This reflects a 4.2% net initial yield at the current passing income of £2.0m pa (based on 50%). Resolution to grant planning consent for a c.240,000 sq ft office-led scheme, which is nearly double the existing floor area, was received in August 2024. Detailed design work is underway.

 

The decision to acquire full control of 50 Baker Street was taken following the pre-letting success at our adjacent 25 Baker Street W1 project and reflects our ongoing confidence in the strength of the West End occupational market. Good progress is being made on a regear of the headleases with The Portman Estate, our freeholder and the owner of 64 Baker Street, to facilitate delivery of this exciting project. This follows our previous regear in 2021 with The Portman Estate at 25 Baker Street. We expect the scheme to deliver an attractive return in line with our current on-site projects.

 

Paul Williams, Chief Executive of Derwent London, said:

"West End vacancy remains low and demand from high quality occupiers across a broad range of business sectors continues to outpace supply. Underpinned by our confidence that the property cycle has inflected, we believe now is the time to acquire well-located regeneration opportunities. Our decision to take full ownership of 50 Baker Street reflects this and marks the conclusion of a successful partnership with Lazari. We look forward to progressing the project to the next stage, with works expected to commence on site in H1 2026."

 

Nicholas Lazari, Director of Lazari Investments, said:

"The sale of our 50% interest in 50 Baker Street marks the culmination of a successful partnership with Derwent London. Following receipt of the resolution to grant planning in August and having made good progress on the regear with The Portman Estate, we feel the time is right to capitalise on our efforts. The cash proceeds from the sale ensures that the equity requirements for our exciting and extensive West End development pipeline are now fully funded and puts us in a strong position to realise opportunities that may arise."

 

 

For further information, please contact:

 

Derwent London

Tel: +44 (0)20 3478 4217 (Robert Duncan)

 

Paul Williams, Chief Executive

Richard Dean, Director of Investment

Robert Duncan, Head of Investor Relations

 

Brunswick Group

Tel: +44 (0)20 7404 5959

 

Nina Coad

Peter Hesse

 

 

Notes to editors

Derwent London plc

Derwent London plc owns 63 buildings in a commercial real estate portfolio predominantly in central London valued at £4.8 billion as at 30 June 2024, making it the largest London office-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1.

As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, publishing its pathway to achieving this goal in July 2020. Our science-based carbon targets validated by the Science Based Targets initiative (SBTi). In 2013 the Company launched a voluntary Community Fund which has to date supported over 160 community projects in the West End and the Tech Belt.

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

For further information see www.derwentlondon.com or follow us on LinkedIn

 

 

Forward-looking statements

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any statements about future outlook involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. Actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements.

No representation or warranty is given in relation to any forward-looking statements made by Derwent London, including as to their completeness or accuracy. Derwent London does not undertake to update any forward-looking statements whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQTTBPTMTMMBPI
Date   Source Headline
29th Mar 201911:00 amRNSTotal Voting Rights
28th Mar 20197:00 amRNSBrunel Building Office Space Fully Pre-Let
21st Mar 201911:00 amRNSDirector/PDMR Shareholding
20th Mar 20191:30 pmRNSBlock listing Interim Review
15th Mar 20193:00 pmRNSHolding(s) in Company
13th Mar 201910:30 amRNSDirector/PDMR Shareholding
12th Mar 201910:00 amRNSDirector/PDMR Shareholding
5th Mar 201910:30 amRNSAdditional Listing
28th Feb 20195:00 pmRNSTotal Voting Rights
27th Feb 20199:30 amRNSHolding(s) in Company
26th Feb 20195:00 pmRNSDividend Declaration
26th Feb 20197:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
18th Feb 20199:00 amRNSHolding(s) in Company
31st Jan 20194:30 pmRNSTotal Voting Rights
28th Dec 20183:00 pmRNSTotal Voting Rights
13th Dec 20185:00 pmRNSHolding(s) in Company
30th Nov 20181:00 pmRNSTotal Voting Rights
30th Nov 201810:00 amRNSInvestor and Analyst Presentation and Tour
23rd Nov 20187:00 amRNSDirectorate Change
22nd Nov 20187:00 amRNS£250 Million US Private Placement
8th Nov 20187:00 amRNSQ3 2018 Business Update
7th Nov 20183:00 pmRNSHolding(s) in Company
31st Oct 20183:00 pmRNSTotal Voting Rights
17th Oct 201811:00 amRNSAdditional Listing
8th Oct 20189:43 amRNSChange of Credit Rating Agency
4th Oct 20184:00 pmRNSHolding(s) in Company
28th Sep 201811:00 amRNSTotal Voting Rights
20th Sep 20183:00 pmRNSBlock listing Interim Review
12th Sep 20185:30 pmRNSDirector/PDMR Shareholding
31st Aug 20181:00 pmRNSTotal Voting Rights
30th Aug 201811:00 amRNSAdditional Listing
28th Aug 20184:00 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSDirectorate Change
9th Aug 20187:00 amRNSHalf-year Results
31st Jul 201811:00 amRNSTotal Voting Rights
30th Jul 201810:00 amRNSHolding(s) in Company
4th Jul 201810:00 amRNSAdditional Listing
2nd Jul 201812:00 pmRNSHolding(s) in Company
29th Jun 20185:00 pmRNSDirector/PDMR Shareholding
29th Jun 20184:30 pmRNSTotal Voting Rights
14th Jun 20183:55 pmRNSSony Pictures Take Leading Role At Brunel Building
31st May 20181:00 pmRNSTotal Voting Rights
25th May 20183:00 pmRNSBlock listing Interim Review
18th May 201812:15 pmRNSResults of 2018 Annual General Meeting
16th May 201811:00 amRNSAdditional Listing
15th May 20185:30 pmRNSBondholders' meeting
10th May 20187:00 amRNSQ1 2018 Business Update
3rd May 20184:21 pmRNSAdjustment to Conversion Price
30th Apr 20186:20 pmRNSTotal Voting Rights
20th Apr 20185:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.